186 related articles for article (PubMed ID: 15773754)
1. Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).
Julien JP; Millecamps S; Kriz J
Novartis Found Symp; 2005; 264():183-92; discussion 192-6, 227-30. PubMed ID: 15773754
[TBL] [Abstract][Full Text] [Related]
2. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.
Millecamps S; Robertson J; Lariviere R; Mallet J; Julien JP
J Neurochem; 2006 Aug; 98(3):926-38. PubMed ID: 16787413
[TBL] [Abstract][Full Text] [Related]
3. Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease.
McLean J; Liu HN; Miletic D; Weng YC; Rogaeva E; Zinman L; Kriz J; Robertson J
J Neurochem; 2010 Aug; 114(4):1177-92. PubMed ID: 20533992
[TBL] [Abstract][Full Text] [Related]
4. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Larivière RC; Beaulieu JM; Nguyen MD; Julien JP
Neurobiol Dis; 2003 Jul; 13(2):158-66. PubMed ID: 12828939
[TBL] [Abstract][Full Text] [Related]
5. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
6. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
Collard JF; Côté F; Julien JP
Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
[TBL] [Abstract][Full Text] [Related]
7. Peripherin immunoreactive structures in amyotrophic lateral sclerosis.
Migheli A; Pezzulo T; Attanasio A; Schiffer D
Lab Invest; 1993 Feb; 68(2):185-91. PubMed ID: 8441252
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
Hadano S; Kunita R; Otomo A; Suzuki-Utsunomiya K; Ikeda JE
Neurochem Int; 2007; 51(2-4):74-84. PubMed ID: 17566607
[TBL] [Abstract][Full Text] [Related]
9. Intermediate filament steady-state mRNA levels in amyotrophic lateral sclerosis.
Strong MJ; Leystra-Lantz C; Ge WW
Biochem Biophys Res Commun; 2004 Apr; 316(2):317-22. PubMed ID: 15020220
[TBL] [Abstract][Full Text] [Related]
10. [From gene to disease: amyotrophic lateral sclerosis].
van Vught PW; Veldink JH; Baas F; van Muiswinkel FL; van den Berg LH
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2125-7. PubMed ID: 15553356
[TBL] [Abstract][Full Text] [Related]
11. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
12. ALS pathogenesis: recent insights from genetics and mouse models.
Swarup V; Julien JP
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):363-9. PubMed ID: 20728492
[TBL] [Abstract][Full Text] [Related]
13. A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient.
Corrado L; Carlomagno Y; Falasco L; Mellone S; Godi M; Cova E; Cereda C; Testa L; Mazzini L; D'Alfonso S
Neurobiol Aging; 2011 Mar; 32(3):552.e1-6. PubMed ID: 20363051
[TBL] [Abstract][Full Text] [Related]
14. A neurotoxic peripherin splice variant in a mouse model of ALS.
Robertson J; Doroudchi MM; Nguyen MD; Durham HD; Strong MJ; Shaw G; Julien JP; Mushynski WE
J Cell Biol; 2003 Mar; 160(6):939-49. PubMed ID: 12642616
[TBL] [Abstract][Full Text] [Related]
15. Isoform-specific expression and ratio changes accompany oxidant-induced peripherin aggregation in a neuroblastoma cell line.
McLean JR; Robertson J
Brain Res; 2011 Nov; 1422():57-65. PubMed ID: 21985957
[TBL] [Abstract][Full Text] [Related]
16. Late onset of motor neurons in mice overexpressing wild-type peripherin.
Beaulieu JM; Nguyen MD; Julien JP
J Cell Biol; 1999 Nov; 147(3):531-44. PubMed ID: 15132161
[TBL] [Abstract][Full Text] [Related]
17. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology.
Xiao S; Tjostheim S; Sanelli T; McLean JR; Horne P; Fan Y; Ravits J; Strong MJ; Robertson J
J Neurosci; 2008 Feb; 28(8):1833-40. PubMed ID: 18287500
[TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.
Lai C; Xie C; McCormack SG; Chiang HC; Michalak MK; Lin X; Chandran J; Shim H; Shimoji M; Cookson MR; Huganir RL; Rothstein JD; Price DL; Wong PC; Martin LJ; Zhu JJ; Cai H
J Neurosci; 2006 Nov; 26(45):11798-806. PubMed ID: 17093100
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
20. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Zhang J; Ito H; Wate R; Ohnishi S; Nakano S; Kusaka H
Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
